Abound Wealth Management Dexcom Inc Transaction History
Abound Wealth Management
- $312 Billion
- Q4 2024
A detailed history of Abound Wealth Management transactions in Dexcom Inc stock. As of the latest transaction made, Abound Wealth Management holds 51 shares of DXCM stock, worth $4,303. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51
Previous 53
3.77%
Holding current value
$4,303
Previous $3.55 Million
11.62%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding DXCM
# of Institutions
1,019Shares Held
351MCall Options Held
5.51MPut Options Held
5.6M-
Vanguard Group Inc Valley Forge, PA47.4MShares$4 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.91 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.51 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.41 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.27 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $32.6B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...